a way to improve the effectiveness of antidepressant therapy in integrated u0430u043du0442u0438u0434u0435u043fu0440u0435u0441u0441u0438u0432u043du043eu0439 therapy and pharmaceutical combination

摘要

the invention is based on the use of acetyl - l - u043au0430u0440u043du0438u0442u0438u043du0430 (afwc) as a means of increasing the efficiency u0430u043du0442u0438u0434u0435u043fu0440u0435u0441u0441u0438u0432u043du043eu0439 therapy and can be applied in the clinic, etc. and u0430u043du0442u0438u0434u0435u043fu0440u0435u0441u0441u0438u0432u043du043eu0439 therapy u0430u043du0442u0438u0434u0435u043fu0440u0435u0441u0441u0430u043du0442u0430u043cu0438 u043du0435u0440u0430u0441u0442u0438u0442u0435u043bu044cu043du043eu0433u043e origin such as agomelatine, venlafaxine, fluvoxamine for the treatment of depressive disorders related to different u0434u0435u043fu0440u0435u0441u0441u0438u0432u043du044b m counts.in particular, depressive episodes in bipolar disorder u0430u0444u0444u0435u043au0442u0438u0432u043du043eu043c, u0440u0435u043au0443u0440u0435u043du0442u043du043eu043c u0434u0435u043fu0440u0435u0441u0441u0438u0432u043du043eu043c disorder, in patients of older age, including p u0430u0446u0438u0435u043du0442u043eu0432 older than 60 years.